Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase co...

por Brown, Mark A, Sims, Robert J, Gottlieb, Paul D, Tucker, Philip W
Publicado 2006

Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation

por Zhu, Li, Brown, Mark A., Sims, Robert J., Tiwari, Gayatri R., Nie, Hui, Mayfield, R. Dayne, Tucker, Haley O.
Publicado 2023

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells

por Bommi-Reddy, Archana, Park-Chouinard, Sungmi, Mayhew, David N., Terzo, Esteban, Hingway, Aparna, Steinbaugh, Michael J., Wilson, Jonathan E., Sims, Robert J., Conery, Andrew R.
Publicado 2022

Accurate, strong, and stable reporting of choroid plexus epithelial cells in transgenic mice using a human transthyretin BAC

por Johnson, Brett A., Coutts, Margaret, Vo, Hillary M., Hao, Xinya, Fatima, Nida, Rivera, Maria J., Sims, Robert J., Neel, Michael J., Kang, Young-Jin, Monuki, Edwin S.
Publicado 2018

Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity

por Stuckey, Jacob I., Cantone, Nico R., Côté, Alexandre, Arora, Shilpi, Vivat, Valerie, Ramakrishnan, Ashwin, Mertz, Jennifer A., Khanna, Avinash, Brenneman, Jehrod, Gehling, Victor S., Moine, Ludivine, Sims, Robert J., Audia, James E., Trojer, Patrick, Levell, Julian R., Cummings, Richard T.
Publicado 2021

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

por Conery, Andrew R, Centore, Richard C, Neiss, Adrianne, Keller, Patricia J, Joshi, Shivangi, Spillane, Kerry L, Sandy, Peter, Hatton, Charlie, Pardo, Eneida, Zawadzke, Laura, Bommi-Reddy, Archana, Gascoigne, Karen E, Bryant, Barbara M, Mertz, Jennifer A, Sims, Robert J
Publicado 2016

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

por Conery, Andrew R, Centore, Richard C, Neiss, Adrianne, Keller, Patricia J, Joshi, Shivangi, Spillane, Kerry L, Sandy, Peter, Hatton, Charlie, Pardo, Eneida, Zawadzke, Laura, Bommi-Reddy, Archana, Gascoigne, Karen E, Bryant, Barbara M, Mertz, Jennifer A, Sims, Robert J
Publicado 2016